Literature DB >> 1732076

Pharmacokinetics of metronidazole in severely malnourished and nutritionally rehabilitated children.

I Lares-Asseff1, J Cravioto, P Santiago, B Pérez-Ortíz.   

Abstract

A comparison of the pharmacokinetics of oral metronidazole, after a single dose of 30 mg/kg body weight, was done in two groups of subjects: group I consisted of 10 severely malnourished children, aged 4 to 43 months; group II consisted of 10 children, aged 3 to 25 months, who were studied after nutritional rehabilitation. The biologic half-life of elimination was significantly longer (p less than 0.01) in severely malnourished children (median, 10.21 hours; range, 4.89 to 22.93 hours) than in rehabilitated children (median, 5.09 hours; range, 2.61 to 8.75 hours). Metabolic clearance of metronidazole was significantly lower in group I (p less than 0.01; median, 0.077 L/kg/hr; range, 0.033 to 0.192 L/kg/hr) than in nutritionally rehabilitated children (median, 0.166 L/kg/hr; range, 0.105 to 0.300 L/kg/hr). Volume of distribution was not different between groups I and II, although both showed higher values than the values reported for children who were not malnourished. These findings suggest that the dose of metronidazole should be reduced in malnourished children, and the therapeutic regimen should be individualized for each patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732076     DOI: 10.1038/clpt.1992.6

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

1.  Perioperative penetration of metronidazole into muscle tissue: a microdialysis study.

Authors:  Juri Karjagin; Rein Pähkla; Joel Starkopf
Journal:  Eur J Clin Pharmacol       Date:  2003-10-29       Impact factor: 2.953

Review 2.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 3.  A systematic review of pharmacokinetics studies in children with protein-energy malnutrition.

Authors:  Kazeem A Oshikoya; Helen M Sammons; Imti Choonara
Journal:  Eur J Clin Pharmacol       Date:  2010-06-16       Impact factor: 2.953

4.  Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients.

Authors:  M I Francke; W J Visser; D Severs; A M E de Mik-van Egmond; D A Hesselink; B C M De Winter
Journal:  Eur J Clin Pharmacol       Date:  2022-05-14       Impact factor: 3.064

Review 5.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 7.  Paediatric labelling requirements. Implications for pharmacokinetic studies.

Authors:  J T Wilson; G L Kearns; D Murphy; S J Yaffe
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

Review 8.  The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies.

Authors:  Meysam Zarezadeh; Ahmad Saedisomeolia; Mahoor Shekarabi; Masoud Khorshidi; Mohammad Reza Emami; Daniel J Müller
Journal:  Eur J Nutr       Date:  2020-11-03       Impact factor: 5.614

9.  Dosing of Ceftriaxone and Metronidazole for Children With Severe Acute Malnutrition.

Authors:  Joseph F Standing; Martin O Ongas; Caroline Ogwang; Nancy Kagwanja; Sheila Murunga; Shalton Mwaringa; Rehema Ali; Neema Mturi; Moline Timbwa; Christine Manyasi; Laura Mwalekwa; Victor L Bandika; Bernhards Ogutu; Joseph Waichungo; Karin Kipper; James A Berkley
Journal:  Clin Pharmacol Ther       Date:  2018-04-19       Impact factor: 6.875

Review 10.  Pharmacokinetics in the infant.

Authors:  R L Milsap; W J Jusko
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.